History
  • No items yet
midpage
912 F.3d 1129
8th Cir.
2019
Read the full case

Background

  • Mancini (California resident) took Mirapex for Parkinson’s from Jan 2006–July 2010 and reported increased gambling/compulsive behaviors to his neurologist in Jan and Apr 2008.
  • Dr. Lew warned Mancini in 2008 that Mirapex may cause compulsive behaviors and advised cutting back; Mancini resisted and continued the drug until July 2010 when his family discovered substantial gambling debts.
  • Mancini sued pharmaceutical defendants in Dec 2010 in multidistrict Mirapex litigation, alleging Mirapex-induced compulsive gambling caused financial losses.
  • Defendants moved for summary judgment on statute-of-limitations grounds under California law (two-year period for drug ingestion personal-injury claims); district court held accrual no later than Apr 23, 2008 and dismissed Mancini’s claims as time-barred.
  • Mancini argued (1) tolling under Cal. Code Civ. Proc. § 352(a) because he was “insane” when the claim accrued, (2) a continuing-violations theory (each dose = new claim), and (3) the district court abused its discretion by denying discovery under Rule 56(d). The district court rejected all three and granted summary judgment.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Tolling for insanity under Cal. Code Civ. Proc. § 352(a) Mancini was "insane" (lacked insight) while on Mirapex, so limitations were tolled until he stopped in July 2010 Mancini was functioning (employment, rental properties, income) and knew Mirapex might cause compulsions, so no tolling No tolling: evidence showed Mancini was capable of managing affairs and understanding nature/effects of his acts when claim accrued; summary judgment affirmed
Continuing violations / accrual per dose Each ingestion of Mirapex creates a separate actionable wrong, so doses within two years of filing are timely The wrongful act was failure to warn/prescribe; accrual occurred when Mancini discovered the connection in early 2008 Rejected: single wrongdoing accrued in early 2008; later harms from continued voluntary use are time-barred
Adequacy of evidence of insanity (material fact) Post-cessation physician notes and Mancini affidavit show lack of insight while medicated Contemporaneous objective evidence (job, income, property management, doctor notes) contradicts insanity claim Court: Mancini failed to show a genuine issue for trial; no reasonable jury could find statutory insanity in early 2008
Denial of Rule 56(d) discovery motion Needed discovery on whether defendants knew Mirapex caused incapacity, relevant to tolling Whether defendants knew is irrelevant to whether Mancini himself was insane when accrual occurred No abuse of discretion: requested discovery would not create a triable issue on Mancini’s personal incapacity

Key Cases Cited

  • Pearl v. Pearl, 177 P. 845 (Cal. 1918) (definition of insanity for tolling includes incapacity to care for property or transact business)
  • Hsu v. Mt. Zion Hosp., 66 Cal. Rptr. 659 (Cal. Ct. App. 1968) (insanity for tolling measured by ability to understand nature/effects of acts and manage affairs)
  • Grisham v. Phillip Morris U.S.A., Inc., 151 P.3d 1151 (Cal. 2007) (single tort yields one claim; continuing accrual applies only to recurring obligations)
  • Aryeh v. Canon Bus. Sols., Inc., 292 P.3d 871 (Cal. 2013) (recurring breaches accrue each time a wrongful act occurs)
  • United Air Lines, Inc. v. Evans, 431 U.S. 553 (1977) (continuing violation/critical question is whether a present violation exists)
  • Gazal v. Boehringer Ingelheim Pharm., Inc., 647 F.3d 833 (8th Cir. 2011) (similar tolling analysis where plaintiff managed business and sought treatment for Mirapex side effects)
  • Ashley v. Boyle’s Famous Corned Beef Co., 66 F.3d 164 (8th Cir. 1995) (continuing violations doctrine; focus on present violation)
  • Nuacke v. City of Park Hills, 284 F.3d 923 (8th Cir. 2002) (summary judgment burden: nonmovant must produce more than scintilla of evidence)
Read the full case

Case Details

Case Name: Mancini v. Boehringer Ingelheim Pharm., Inc. (In Re Mirapex Prods. Liab. Litig.)
Court Name: Court of Appeals for the Eighth Circuit
Date Published: Jan 10, 2019
Citations: 912 F.3d 1129; 17-2204
Docket Number: 17-2204
Court Abbreviation: 8th Cir.
Log In